ArticleAmerican journal of translational research2025
Regression analysis and validation of risk factors for upper limb dysfunction following modified radical mastectomy for breast cancer patients.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond surgical risk: Multidimensional predictors of postoperative arm morbidity after breast cancer treatment.Breast (Edinburgh, Scotland) · 2026Article
- Comparison of Feature Selection Methods in Machine Learning Models of Cancer Information Seeking Among United States Adults: Cross-Sectional Study.JMIR medical informatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop and validate a predictive tool using machine learning models for identifying risk factors for upper limb dysfunction following modified radical mastectomy (MRM) in breast cancer patients.
methodsA total of 768 breast cancer patients who underwent Modified radical mastectomy (MRM) between January 2022 and December 2023 were included in this study. The dataset was divided into a training set (506 cases) and a validation set (262 cases). The collected data encompassed demographic characteristics, clinicopathological features, medical history, and postoperative rehabilitation plans. Predictive analyses were conducted using machine learning models, including support vector machine (SVM), extreme gradient boosting (XGBOOST), Gaussian naïve Bayes (GNB), adaptive boosting (ADABOOST), and random forest. Model evaluation was performed using ten-fold cross-validation, with performance metrics including receiver operating characteristic (ROC) curves, area under the curve (AUC) values, specificity, sensitivity, accuracy, and F1-score. DeLong's test was used to compare AUC values and identify the optimal predictive model.
resultsBaseline characteristics showed no significant differences between the training and validation sets (P>0.05). Analysis of factors associated with upper limb dysfunction in the training set revealed significant differences in variables such as age, BMI, cancer type, axillary lymph node dissection, ipsilateral radiotherapy, postoperative rehabilitation plans, and monthly per capita household income (P<0.05). Low correlations were observed among these variables (R values close to 0), indicating minimal multicollinearity. Model performance evaluation showed that the XGBOOST and random forest models demonstrated high AUC values (0.817-0.884) across both the training and validation sets. These models also exhibited superior specificity and sensitivity, indicating strong predictive performance and robustness in identifying patients at risk of postoperative upper limb dysfunction.
conclusionThe XGBOOST and random forest models exhibited excellent predictive accuracy, offering valuable tools for the early identification and personalized management of high-risk patients. These models provide critical data support for postoperative rehabilitation planning and contribute to improving the quality of life for breast cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.